City of Hope – The first patient to receive City of Hope’s novel, promising cancer medicine AOH1996 is doing well

LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient to receive its novel, promising cancer medicine AOH1996 is doing well. The Phase 1 clinical trial testing the safety of a potentially cancer-stopping therapeutic developed by City of Hope in…

Read More

Aspirin and Cancer: the Emerging Evidence

Professor Peter Elwood Honorary Professor, Cardiff University There is a remarkable harmony between the effects of aspirin on the biological mechanisms of cancer metabolism and growth, and clinical evidence of reductions in cancer mortality and metastatic cancer spread. Although aspirin increases the number of bleeds, the severity of bleeds attributable to aspirin is low, and…

Read More